Global Pneumococcal Vaccination Market Growth 2025-2031

The global Pneumococcal Vaccination market size is predicted to grow from US$ 10310 million in 2025 to US$ 19320 million in 2031; it is expected to grow at a CAGR of 11.0% from 2025 to 2031.

Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.

The pneumococcal vaccination market is driven by the increasing awareness of the importance of vaccination and the rising incidence of pneumococcal infections. Pneumococcal vaccines are crucial in preventing diseases caused by Streptococcus pneumoniae bacteria, such as pneumonia, meningitis, and bacteremia. The rise in the geriatric population and the need for immunization against respiratory infections contribute to market growth as pneumococcal vaccines offer significant benefits in reducing morbidity and mortality. Moreover, advancements in vaccine technology, such as the introduction of conjugate vaccines for broader protection, have improved vaccine efficacy. However, the market also faces challenges, including vaccine supply constraints and the need for continuous research to address emerging pneumococcal serotypes and strains. Additionally, addressing vaccine hesitancy and increasing vaccination coverage in underserved populations can pose obstacles for comprehensive disease prevention. To succeed, companies must focus on research and development to offer innovative and affordable pneumococcal vaccines, collaborate with healthcare providers to promote vaccination recommendations, and address the challenges to meet the increasing demand for effective and accessible protection against pneumococcal infections.

LP Information, Inc. (LPI) ' newest research report, the “Pneumococcal Vaccination Industry Forecast” looks at past sales and reviews total world Pneumococcal Vaccination sales in 2024, providing a comprehensive analysis by region and market sector of projected Pneumococcal Vaccination sales for 2025 through 2031. With Pneumococcal Vaccination sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pneumococcal Vaccination industry.

This Insight Report provides a comprehensive analysis of the global Pneumococcal Vaccination landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pneumococcal Vaccination portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pneumococcal Vaccination market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pneumococcal Vaccination and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pneumococcal Vaccination.

This report presents a comprehensive overview, market shares, and growth opportunities of Pneumococcal Vaccination market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
PPSV 23
PCV 13
PCV 10

Segmentation by Application:
Child
Adult

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Pfizer
GSK
MSD
CDIBP
WALVAX
Sinovac
Bio Kangtai

Key Questions Addressed in this Report

What is the 10-year outlook for the global Pneumococcal Vaccination market?

What factors are driving Pneumococcal Vaccination market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Pneumococcal Vaccination market opportunities vary by end market size?

How does Pneumococcal Vaccination break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.